As of 12:23pm ET
| -0.05 / -0.96%|
The 1 analysts offering 12-month price forecasts for Arcturus Therapeutics Ltd have a median target of 12.00, with a high estimate of 12.00 and a low estimate of 12.00. The median estimate represents a +133.01% increase from the last price of 5.15.
The current consensus among 2 polled investment analysts is to Buy stock in Arcturus Therapeutics Ltd. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.